Novel, potent phenethylamide inhibitors of the hepatitis C virus (HCV) NS3 protease: Probing the role of P2 aryloxyprolines with hybrid structures

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 16, 2003, Pages 2745-2748

  Orvieto, Federica ^a   Koch, Uwe ^a   Matassa, Victor G ^a,b   Muraglia, Ester ^a  

^a IRBM   (Italy)

^b Graffinity Pharmaceuticals AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; NS3 PROTEINASE; PROLINE DERIVATIVE; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS ENZYME;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HEPATITIS C VIRUS; MOLECULAR MODEL;

HEPATITIS C VIRUS;

EID: 0038149010     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00536-5     Document Type: Article

References (16)

1. Beaulieu P.L., Llinas-Brunet M. Curr. Med. Chem. Anti-Infect. Agents. 1:2002;163.
2. Steinkühler C., Koch U., Narjes F., Matassa V.G. Curr. Med. Chem. 8:2001;919. and refs therein.
3. Ingallinella P., Altamura S., Bianchi E., Taliani M., Ingenito R., Cortese R., De Francesco R., Steinkühler C., Pessi A. Biochemistry. 37:1998;8906.
4. Llinas-Brunet M., Bailey M.D., Fazal G., Goulet S., Halmos T., Laplante S., Maurice R., Poirer M., Poupart M.-A., Thibeault D., Wernic D.M., Lamarre D. Bioorg. Med. Chem. Lett. 8:1998;1713.
5. Colarusso S., Gerlach B., Koch U., Muraglia E., Conte I., Stansfield I., Matassa V., Narjes F. Bioorg. Med. Chem. Lett. 12:2002;705.
6. Di Marco S., Rizzi M., Volpari C., Walsh M.A., Narjes F., Colarusso S., De Francesco R., Matassa V.G., Sollazzo M. J. Biol. Chem. 275:2000;7152.
7. Barbato G., Cicero D.O., Cordier F., Narjes F., Gerlach B., Sambucini S., Grzesiek S., Matassa V.G., De Francesco R., Bazzo R. EMBO J. 19:2000;1195.
8. Colarusso S., Koch U., Gerlach B., Steinkühler C., De Francesco R., Altamura S., Matassa V.G., Narjes F. J. Med. Chem. 46:2003;345.
9. Unpublished results.
10. Llinas-Brunet, M.; Bailey, M. D.; Cameron, D.; Faucher, A.-M.; Ghiro, E.; Goudreau, N.; Halmos, T.; Poupart, M.-A.; Rancourt, J.; Tsantrizos, Y. S.; Wernic, D. M.; Simoneau, B. PCT Int. Appl. 2000, WO 00/09543.
11. Gallinari P., Paolini C., Brennan D., Nardi C., Steinkühler C., De Francesco R. Biochemistry. 38:1999;5620.
12. Narjes F., Koehler K.F., Koch U., Gerlach B., Colarusso S., Steinkühler C., Brunetti M., Altamura S., De Francesco R., Matassa V.G. Bioorg. Med. Chem. Lett. 12:2002;701.
13. Narjes, F. et al. Manuscript in preparation.
14. For α-hydroxy acid capped dipeptide HCV inhibitors, see: Nizi E., Koch U., Ponzi S., Matassa V.G., Gardelli C. Bioorg. Med. Chem. Lett. 12:2002;3325.
15. 1H NMR, MS and RP-HPLC.
16. Carpino L.A., Mansour E.-S.M.E., Sadat-Aalaee D. J. Org. Chem. 56:1991;2611.